Meghmani Organics Ltd (BOM:543331)

Q1 2027 Meghmani Organics Ltd Earnings Call Transcript

Jul 30, 2026 / 11:30 AM GMT

Release Date Price: ₹55.21 (-1.94%)

Transcript

Key Points

Positve

Net profit grew 42% YoY on a standalone basis and 280% YoY on a consolidated basis, driven by a focus on product mix optimization and disciplined pricing.
Consolidated EBITDA margin expanded significantly to 18% from 10.9% in the same quarter last year, reflecting improved operational efficiencies.
The crop nutrition segment delivered positive contributions, with new nano fertilizer products (Nano DAP, Nano NPK, Nano Zinc) complementing Nano Urea and driving growth.
Management is optimistic about double-digit top-line growth in the crop protection segment over the next 2-3 years, supported by investments in new registrations and product development.
The company is focused on debt reduction, having repaid approximately INR 32 crore in Q1 FY27, with plans for continued repayment and no heavy CapEx for the next 1-2 years.
Low inventory levels at distributors and customers in both crop protection and pigment segments are a positive sign, indicating healthy underlying demand.
The pigment segment's EBITDA margin improved significantly to 12.1% from 3% in the prior year, aided by better realization and operational cost reductions.
The amalgamation of wholly-owned subsidiaries is progressing, expected to bring operational synergies and cost reductions.

Negative

Revenue declined 12% YoY on both standalone and consolidated bases due to softer demand across key export and domestic markets, with volumes down 17%.
Capacity utilization remains low, particularly in the pigment segment at 39%, and is expected to stay in the 40-50% range due to market overcapacity.
Titanium dioxide operations remain suspended due to commercial unviability, with raw material (sulfur) prices having surged 8-10 times, and no clear timeline for resumption.
The company faces ongoing macroeconomic uncertainties and volatile raw material prices, making it difficult to predict pricing trends and demand in the near term.
The pigment segment's revenue is expected to remain stable at INR 500-600 crore annually, with management prioritizing profitability over top-line growth in a stagnant industry.
The titanium dioxide segment reported a negative EBITDA of nearly INR 3 crore in Q1, with annualized losses of INR 10-12 crore if operations remain suspended.
Management expects overall consolidated EBITDA margins to be in the 12-13% range, which is lower than the 18% achieved in Q1 FY27, indicating a potential normalization.
The company is not planning significant CapEx in the pigment segment, limiting its growth potential in that area.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MEGI.NS - Meghmani Organics Ltd
Q1 2027 Meghmani Organics Ltd Earnings Call
Jul 30, 2026 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, good day and welcome to Make Money Organics Limited Q1 FY27 conference call.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing then 0 on a touchstone phone. Please note that this conference has been recorded. I now hand the conference over to Ms. Rashmi Goel from Aryan. Capital markets.

Thank you and over to you ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.